{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T20:33:59Z","timestamp":1775075639029,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T00:00:00Z","timestamp":1307232000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00296-011-1968-x","type":"journal-article","created":{"date-parts":[[2011,6,4]],"date-time":"2011-06-04T10:43:55Z","timestamp":1307184235000},"page":"2367-2370","source":"Crossref","is-referenced-by-count":9,"title":["Using TNF-alpha antagonist Adalimumab for treatment for multisystem sarcoidosis: a case study"],"prefix":"10.1007","volume":"32","author":[{"given":"Tobias","family":"Lahmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Knopf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Lanzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Heemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Thuermel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,5]]},"reference":[{"key":"1968_CR1","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(03)12888-7","volume":"36","author":"RP Baughman","year":"2003","unstructured":"Baughman RP, Lower EE, du Bois RM (2003) Sarcoidosis. Lancet 36:1111\u20131118","journal-title":"Lancet"},{"key":"1968_CR2","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1001\/jama.289.24.3300","volume":"289","author":"KW Thomas","year":"2003","unstructured":"Thomas KW, Hunninghake GW (2003) Sarcoidosis. JAMA 289:3300\u20133303","journal-title":"JAMA"},{"key":"1968_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00002281-200001000-00012","volume":"12","author":"C Agostini","year":"2000","unstructured":"Agostini C, Adami F, Semenzato G (2000) New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 12:71\u201376","journal-title":"Curr Opin Rheumatol"},{"key":"1968_CR4","first-page":"289","volume-title":"Tumor necrosis factor alpha. The cytokine handbook","author":"KJ Tracey","year":"1994","unstructured":"Tracey KJ (1994) Tumor necrosis factor alpha. The cytokine handbook, 2nd edn. Academic press, Ney York, pp 289\u2013304","edition":"2"},{"key":"1968_CR5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2002.004226","volume":"63","author":"C Pritchard","year":"2004","unstructured":"Pritchard C, Nadarajah K (2004) Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients. Ann Rheum Dis 63:318\u2013320","journal-title":"Ann Rheum Dis"},{"key":"1968_CR6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ccm.2008.03.012","volume":"29","author":"RP Baughman","year":"2008","unstructured":"Baughman RP, Costabel U, du Bois RM (2008) Treatment of sarcoidosis. Clin Chest Med 29:533\u2013548","journal-title":"Clin Chest Med"},{"key":"1968_CR7","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1002\/art.11357","volume":"48","author":"KU Ulbricht","year":"2003","unstructured":"Ulbricht KU, Stoll M, Bierwirth J et al (2003) Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 48:3542\u20133543","journal-title":"Arthritis Rheum"},{"key":"1968_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2796.2003.01075.x","volume":"253","author":"DR Moller","year":"2003","unstructured":"Moller DR (2003) Treatment of sarcoidosis from a basic science point of view. J Intern Med 253:31\u201340","journal-title":"J Intern Med"},{"key":"1968_CR9","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ccm.2004.04.006","volume":"25","author":"RP Baughman","year":"2004","unstructured":"Baughman RP (2004) Pulmonary sarcoidosis. Clin Chest Med 25:521\u2013530","journal-title":"Clin Chest Med"},{"key":"1968_CR10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00415-005-0043-5","volume":"253","author":"S Marangoni","year":"2006","unstructured":"Marangoni S, Argentiero V, Tavolato B (2006) Neurosarcoidosis: clinical description of 7 cases with a proposal for a new diagnostic strategy. J Neurol 253:488\u2013495","journal-title":"J Neurol"},{"key":"1968_CR11","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/archinte.1997.00440370104011","volume":"157","author":"EE Lower","year":"1997","unstructured":"Lower EE, Broderick JP, Brott TG et al (1997) Diagnosis and management of neurological sarcoidosis. Arch Int Med 157:1864\u20131868","journal-title":"Arch Int Med"},{"key":"1968_CR12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9394(86)90001-2","volume":"102","author":"DA Jabs","year":"1986","unstructured":"Jabs DA, Johns CA (1986) Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 102:297\u2013301","journal-title":"Am J Ophthalmol"},{"key":"1968_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5414\/CPP43007","volume":"43","author":"RP Baughman","year":"2005","unstructured":"Baughman RP, Bradley DA, Lower EE (2005) Infl iximab in chronic ocular inflammation. Int J Clin Pharmacol Ther 43:7\u201311","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1968_CR14","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.127.3.1064","volume":"127","author":"JD Doty","year":"2005","unstructured":"Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064\u20131071","journal-title":"Chest"},{"issue":"7","key":"1968_CR15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","volume":"174","author":"RP Baughman","year":"2006","unstructured":"Baughman RP, Drent M, Kavuru M et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174(7):795\u2013802 (Epub 2006 July 13)","journal-title":"Am J Respir Crit Care Med"},{"issue":"72","key":"1968_CR16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/01.wnl.0000341278.26993.22","volume":"27","author":"M Moravan","year":"2009","unstructured":"Moravan M, Segal BM (2009) Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 27(72):337\u2013340","journal-title":"Neurology"},{"key":"1968_CR17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1378\/chest.124.1.177","volume":"124","author":"JP Utz","year":"2003","unstructured":"Utz JP, Limper AH, Kalra S et al (2003) Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest 124:177\u2013185","journal-title":"Chest"},{"key":"1968_CR18","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.22238","volume":"55","author":"MA Gonzalez-Lopez","year":"2006","unstructured":"Gonzalez-Lopez MA, Blanco R, Gonzalez-Vela MC et al (2006) Development of sarcoidosis during etanercept therapy. Arthritis Rheum 55:817\u2013820","journal-title":"Arthritis Rheum"},{"key":"1968_CR19","doi-asserted-by":"crossref","unstructured":"Skoie IM, Wildhagen K, Omdal R (2010) Development of sarcoidosis following etanercept treatment: a report of three cases. Rheumatol Int [Epub ahead of print]","DOI":"10.1007\/s00296-009-1349-x"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1968-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-1968-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-1968-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T08:07:34Z","timestamp":1560240454000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-1968-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,5]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["1968"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-1968-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,5]]}}}